# SAL3
## History
```mermaid
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
    title Publication timing
      2022-07-06 : Burkhardt : BL
```
## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|![BL](images/icons/BL_tier2.png)    |2   |relevance in BL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|BL    |GAMBL genomes+capture|NA           |
|BL    |Thomas cohort        |NA           |
|BL    |Panea cohort         |NA           |



View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/SAL3_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/SAL3_protein_hg38.html)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/SAL3.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/SAL3_hg38.html)

![image](images/proteinpaint/SAL3.svg)
## SAL3 Expression
![image](images/gene_expression/SAL3_by_pathology.svg)
<!-- ORIGIN: burkhardtClinicalRelevanceMolecular2022b -->
<!-- BL: burkhardtClinicalRelevanceMolecular2022b -->
## References
1.  Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, GÃ¶kbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
